Pacific Biosciences Of California, Inc. SEC filings PACB

Pacific Biosciences Of California, Inc. has 971 filings in SEC EDGAR's recent list, going back to Jul 28, 2004. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, officer or director change). The company's fiscal year ends on December 31.

Pacific Biosciences Of California, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Officer or director change
Nov 4, 2026 Nov 3, 2026
4 Insider transaction Oct 8, 2026 Oct 6, 2026
144 Notice of proposed sale Oct 6, 2026 —
4 Insider transaction Aug 18, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 11, 2026 Aug 10, 2026
S-8 Employee stock plan registration Aug 7, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations, Exit or restructuring costs, Officer or director change, Regulation FD disclosure
Aug 5, 2026 Jul 30, 2026
8-K Current report
Officer or director change
Jul 9, 2026 Jul 8, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 4, 2026 Jun 3, 2026
SD Specialized disclosure (conflict minerals) May 27, 2026 —
DEFA14A Additional proxy material May 22, 2026 —
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 3, 2026
4 Insider transaction Apr 10, 2026 Apr 8, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 6, 2026 Mar 2, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
3 Initial insider ownership Mar 5, 2026 Mar 3, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 4, 2026 Mar 3, 2026
4 Insider transaction Mar 4, 2026 Mar 3, 2026
4 Insider transaction Mar 4, 2026 Mar 3, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Mar 3, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
S-3ASR Automatic shelf registration Feb 25, 2026 —
S-8 Employee stock plan registration Feb 25, 2026 —
10-K Annual report Feb 25, 2026 Dec 31, 2025
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
8-K Current report
Results of operations
Feb 12, 2026 Feb 12, 2026
8-K Current report
Officer or director change
Feb 3, 2026 Jan 28, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 3, 2026 —
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Feb 2, 2026 Jan 30, 2026
8-K Current report
Results of operations, Other events
Jan 12, 2026 Jan 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 4, 2025 —
4 Insider transaction Aug 20, 2025 Aug 18, 2025
144 Notice of proposed sale Aug 18, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
S-8 Employee stock plan registration Aug 7, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 24, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
SD Specialized disclosure (conflict minerals) May 29, 2025 —
4 Insider transaction May 21, 2025 May 19, 2025
DEFA14A Additional proxy material May 20, 2025 —
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 30, 2025 —
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 23, 2025 —
DEF 14A Proxy statement Apr 23, 2025 Jun 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 9, 2025 —
8-K Current report
Results of operations, Exit or restructuring costs
Apr 9, 2025 Apr 9, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
3 Initial insider ownership Apr 2, 2025 Mar 31, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 27, 2025 Mar 24, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
S-8 Employee stock plan registration Mar 17, 2025 —
10-K Annual report Mar 17, 2025 Dec 31, 2024
8-K Current report
Material agreement, New debt
Mar 13, 2025 Mar 7, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
4 Insider transaction Feb 19, 2025 Feb 18, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
144 Notice of proposed sale Feb 18, 2025 —
144 Notice of proposed sale Feb 18, 2025 —
8-K Current report
Results of operations
Feb 13, 2025 Feb 13, 2025
8-K/A Amended current report
Officer or director change
Feb 7, 2025 Jan 24, 2025
4 Insider transaction Feb 3, 2025 Jan 30, 2025
3 Initial insider ownership Feb 3, 2025 Jan 30, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 30, 2025 Jan 24, 2025
8-K Current report
Results of operations, Other events
Jan 14, 2025 Jan 14, 2025
4 Insider transaction Jan 10, 2025 Jan 10, 2025
144 Notice of proposed sale Jan 10, 2025 —
POSASR Filing Jan 10, 2025 —
8-K Current report
Officer or director change
Dec 13, 2024 Dec 11, 2024
8-K/A Amended current report
Officer or director change
Dec 13, 2024 Nov 11, 2024
SCHEDULE 13G Ownership over 5% (passive) Dec 10, 2024 —
8-K Current report
Officer or director change
Dec 6, 2024 Dec 5, 2024
SC 13G Ownership over 5% (passive) Nov 26, 2024 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Nov 22, 2024 Nov 21, 2024
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
8-K Current report
Officer or director change
Nov 12, 2024 Nov 11, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
8-K Current report
Results of operations, Officer or director change
Nov 7, 2024 Nov 5, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Nov 7, 2024 Nov 7, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
4 Insider transaction Oct 2, 2024 Sep 30, 2024
144 Notice of proposed sale Sep 30, 2024 —
4 Insider transaction Sep 17, 2024 Sep 16, 2024
144 Notice of proposed sale Sep 16, 2024 —
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Aug 20, 2024 Aug 16, 2024
144 Notice of proposed sale Aug 19, 2024 —
144 Notice of proposed sale Aug 16, 2024 —
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K/A Amended current report
Exit or restructuring costs
Aug 7, 2024 Apr 16, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
S-8 Employee stock plan registration Jun 20, 2024 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 20, 2024 Jun 18, 2024
SD Specialized disclosure (conflict minerals) May 30, 2024 —
DEFA14A Additional proxy material May 30, 2024 —
4 Insider transaction May 22, 2024 May 20, 2024
S-3ASR Automatic shelf registration May 9, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 18, 2024
8-K Current report
Results of operations, Exit or restructuring costs, Other events
Apr 16, 2024 Apr 16, 2024
PRE 14A Preliminary proxy statement Apr 15, 2024 Jun 18, 2024
POSASR Filing Apr 11, 2024 —
POSASR Filing Apr 11, 2024 —
POSASR Filing Apr 11, 2024 —
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 6, 2024 Mar 6, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
144 Notice of proposed sale Mar 4, 2024 —
144 Notice of proposed sale Mar 4, 2024 —
144 Notice of proposed sale Mar 4, 2024 —
S-8 Employee stock plan registration Feb 29, 2024 —
10-K Annual report Feb 28, 2024 Dec 31, 2023
4 Insider transaction Feb 26, 2024 Feb 22, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
4 Insider transaction Feb 26, 2024 Feb 22, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
144 Notice of proposed sale Feb 20, 2024 —
144 Notice of proposed sale Feb 20, 2024 —
144 Notice of proposed sale Feb 16, 2024 —
144 Notice of proposed sale Feb 16, 2024 —
144 Notice of proposed sale Feb 16, 2024 —
144 Notice of proposed sale Feb 16, 2024 —
8-K Current report
Results of operations
Feb 15, 2024 Feb 15, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 5, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
PACB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Menlo Park, CA
SEC filer status
Accelerated filer
SEC CIK
1299130
Former names
PACIFIC BIOSCIENCES OF CALIFORNIA INC (until Feb 5, 2013); NANOFLUIDICS INC (until Jul 28, 2004)

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.